Skip to content

Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric

Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth: A Randomized Clinical Trial

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03962634
Enrollment
3
Registered
2019-05-24
Start date
2019-08-28
Completion date
2019-09-17
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apical Periodontitis, Caries,Dental

Keywords

Cavities

Brief summary

The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.

Detailed description

In June 2016, an intranasal delivery system of local anesthesia called Kovanaze, gained FDA approval. \[9\] Kovanaze is available as a 0.2 ml metered spray and is intended to achieve pulpal anesthesia of 5 maxillary teeth on either side of the face. Even though success rates between 83 and 90 % have been reported for adults and children \>40kg, \[10\] FDA label (Section 14.2) provides data for children (\>10 kg) indicating that the drug is safe for use in children as long as the dose is adjusted to bodyweight of the child. \[9\] * One 0.1 mL spray for patients weighing 10 kg to less than 20 kg; * Two 0.1 mL sprays for 20 kg to less than 40 kg; or * Two 0.2 mL sprays for patients weighing 40 kg or more. With the ability to avoid the traditional painful injection Kovanaze offers promise in the field of maxillary anesthesia and this study intends to: 1. Compare Kovanaze to conventional needle anesthetic children (at least 6 years of age and weighing \> 20 kg) 2. Evaluate patient anxiety, tolerance and acceptability of Kovanaze in patients undergoing dental procedures

Interventions

Intra-nasal local anesthetic

Local anesthetic

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists Class I or II * Preoperative heart rate of 55 to 100 beats per minute * Maximum blood pressure reading of 166/100 mmHg * Treatment for a pathology in the maxillary anterior tooth or premolar that requires administering local anesthesia Additional Pediatric Inclusion Criteria: * Children \>20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth Additional Endodontic Inclusion Criteria: * Adults (\>18 years) who require non-surgical root canal treatment in maxillary anterior teeth Additional General Practice Inclusion Criteria: * Adults who require restorations in the maxillary teeth that would need local anesthesia

Exclusion criteria

* Inadequately controlled thyroid disease * Five or more nosebleeds in the past month * Known allergy to any study drug or para-aminobenzoic acid * History of methemoglobinemia * Taking monoamine oxidase inhibitors, tricyclic antidepressants (i.e. amitriptyline), or non-selective beta adrenergic antagonists (i.e. propranolol); * Taking oxymetazoline-containing products (i.e., Afrin) in the last 24 hours.

Design outcomes

Primary

MeasureTime frameDescription
Success Rate of Pupal Anesthesiaimmediately after dental procedure, an average of 3 hours% dental procedures completed without the need for rescue anesthesia

Secondary

MeasureTime frameDescription
Change in Anxiety Levelfrom baseline to immediately after dental procedureSTAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.
Anxietyimmediately after dental procedure, an average of 3 hoursVenham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)
Spread of Anesthesiaimmediately after dental procedure, an average of 3 hoursNumber of teeth anesthetized in maxillary arch
Change in Heart Ratefrom baseline to immediately after dental procedure
Change in Painfrom baseline to immediately after dental procedureEmoji scale ranging from 1 (very negative face) to 7 (very positive face)
Change in Blood Pressurefrom baseline to immediately after dental procedure

Countries

United States

Participant flow

Participants by arm

ArmCount
Kovanaze Nasal Spray (Pediatrics)
Children \>20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth Kovanaze Nasal Spray: Intra-nasal local anesthetic
1
Articaine Injections (Pediatrics)
Children \>20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth Articaine Injection: Local anesthetic
2
Total3

Baseline characteristics

CharacteristicTotalKovanaze Nasal Spray (Pediatrics)Articaine Injections (Pediatrics)
Age, Continuous— years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
3 participants1 participants2 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 10 / 2
other
Total, other adverse events
0 / 10 / 2
serious
Total, serious adverse events
0 / 10 / 2

Outcome results

Primary

Success Rate of Pupal Anesthesia

% dental procedures completed without the need for rescue anesthesia

Time frame: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Anxiety

Venham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)

Time frame: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Change in Anxiety Level

STAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.

Time frame: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Change in Blood Pressure

Time frame: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Change in Heart Rate

Time frame: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Change in Pain

Emoji scale ranging from 1 (very negative face) to 7 (very positive face)

Time frame: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Secondary

Spread of Anesthesia

Number of teeth anesthetized in maxillary arch

Time frame: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026